|Title: ||Hypertension in rheumatoid arthritis|
|Citation: ||Rheumatology, 47(9): 1286-1298|
|Publisher: ||Oxford University Press|
|Issue Date: ||2008 |
|PubMed ID: ||18467370|
|Additional Links: ||http://rheumatology.oxfordjournals.org/cgi/content/abstract/47/9/1286|
|Abstract: ||RA associates with an increased burden of cardiovascular disease, which is at least partially attributed to classical risk factors such as hypertension (HT) and dyslipidaemia. HT is highly prevalent, and seems to be under-diagnosed and under-treated among patients with RA. In this review, we discuss the mechanisms that may lead to increased blood pressure in such patients, paying particular attention to commonly used drugs for the treatment of RA. We also suggest screening strategies and management algorithms for HT, specific to the RA population, although it is clear that these need to be formally assessed in prospective randomized controlled trials designed specifically for the purpose, which, unfortunately, are currently lacking.|
Non-steroidal anti-inflammatory drugs
|MeSH: ||Anti-Inflammatory Agents, Non-Steroidal|
|Appears in Collections: ||Sport, Exercise and Health Research Group|
|Files in This Item:|
There are no files associated with this item.
All Items in WIRE are protected by copyright, with all rights reserved, unless otherwise indicated.